These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 29870500)
1. Drug-induced lupus erythematosus: an update on drugs and mechanisms. He Y; Sawalha AH Curr Opin Rheumatol; 2018 Sep; 30(5):490-497. PubMed ID: 29870500 [TBL] [Abstract][Full Text] [Related]
2. Drug-induced lupus erythematosus. Vedove CD; Del Giglio M; Schena D; Girolomoni G Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892 [TBL] [Abstract][Full Text] [Related]
3. Drug-induced lupus: an update on its dermatologic aspects. Marzano AV; Vezzoli P; Crosti C Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393 [TBL] [Abstract][Full Text] [Related]
4. Drug-induced lupus erythematosus. Pretel M; Marquès L; España A Actas Dermosifiliogr; 2014; 105(1):18-30. PubMed ID: 23164669 [TBL] [Abstract][Full Text] [Related]
5. Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agents. Dalle Vedove C; Simon JC; Girolomoni G J Dtsch Dermatol Ges; 2012 Dec; 10(12):889-97. PubMed ID: 22937775 [TBL] [Abstract][Full Text] [Related]
7. Pearls for the diagnosis and possible pathophysiological mechanisms of valproic acid-induced lupus erythematosus: A literature review. Papadopoulou E; Saroglou M; Ismailos G; Fletsios D; Tsavlis D; Tryfon S Lupus; 2022 May; 31(6):650-658. PubMed ID: 35324365 [No Abstract] [Full Text] [Related]
8. Drug-induced lupus due to anti-tumor necrosis factor alpha agents. Costa MF; Said NR; Zimmermann B Semin Arthritis Rheum; 2008 Jun; 37(6):381-7. PubMed ID: 17977585 [TBL] [Abstract][Full Text] [Related]
10. Drug-induced lupus erythematosus presenting with cardiac tamponade: a case report and literature review. Harnett DT; Chandra-Sekhar HB; Hamilton SF Can J Cardiol; 2014 Feb; 30(2):247.e11-2. PubMed ID: 24373757 [TBL] [Abstract][Full Text] [Related]
11. Drug-induced lupus erythematosus: incidence, management and prevention. Chang C; Gershwin ME Drug Saf; 2011 May; 34(5):357-74. PubMed ID: 21513360 [TBL] [Abstract][Full Text] [Related]
12. Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent. Subramanian S; Yajnik V; Sands BE; Cullen G; Korzenik JR Inflamm Bowel Dis; 2011 Jan; 17(1):99-104. PubMed ID: 20629183 [TBL] [Abstract][Full Text] [Related]
13. Drug-induced lupus: an update. Vasoo S Lupus; 2006; 15(11):757-61. PubMed ID: 17153847 [TBL] [Abstract][Full Text] [Related]
14. Drug-induced systemic lupus erythematosus in a child after 3 years of treatment with carbamazepine. Molina-Ruiz AM; Lasanta B; Barcia A; Pérez-Vega E; Requena L Australas J Dermatol; 2017 Feb; 58(1):e20-e22. PubMed ID: 26424435 [TBL] [Abstract][Full Text] [Related]
15. Drug-induced lupus erythematosus in childhood: Case-based review. Kaya Akca U; Sener S; Batu ED; Balik Z; Basaran O; Bilginer Y; Ozen S Lupus; 2024 Jun; 33(7):737-748. PubMed ID: 38580326 [TBL] [Abstract][Full Text] [Related]
16. Anti-TNF-α and hydralazine drug-induced lupus. Quaresma MV; Bernardes Filho F; Oliveira FB; Pockstaller MP; Dias MF; Azulay DR An Bras Dermatol; 2015; 90(3 Suppl 1):125-9. PubMed ID: 26312694 [TBL] [Abstract][Full Text] [Related]